Long-Term Outcomes of Staged Non-Culprit Lesions Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting with ST-segment Elevation Myocardial Infarction

Tatyana Levinas Cardiology, Ziv Medical Center, Israel Irena Nordkin Cardiology, Ziv Medical Center, Israel Valentin Belinson Cardiology, Ziv Medical Center, Israel Inna Rosenfeld Cardiology, Ziv Medical Center, Israel Majdi Halabi Cardiology, Ziv Medical Center, Israel

Background and Objectives:
Multivessel coronary artery disease (MVD) is frequently (40-60%) encountered in patients with ST elevation myocardial infarction (STEMI) and it has been associated with worse clinical course.
Long-term outcomes of percutaneous coronary interventional (PCI) strategy for dealing with significant non-culprit lesion in patients with multi-vessel disease after STEMI are conflicting and optimal timing of non-culprit lesion revascularization is not well investigated.
This study aimed to determine outcomes of staged complete multivessel PCI (MV-PCI) in patients with STEMI compared with culprit only PCI.

Methods:
This study was a retrospective analysis of the patients with STEMI and MVD, treated by primary percutaneous coronary intervention (PPCI), follow-up was one year after admission with STEMI.
Patients were divided into 2 groups: group of patients who completed the staged PCI for the non-infarct related artery (with sub analysis of timing staged PCI) and culprit only revascularization group.
We performed analysis of both groups for MACE: mortality (cardiac and non-cardiac), recurrence of hospitalization due to cardiovascular causes, incidence of repeat revascularization or the need for coronary artery bypass graft (CABG) procedure during a year follow up after STEMI.

Results:
Staged non-culprit lesions PCI was planned in 92 patients, staged complete multivessel PCI was performed in 56 patients (60%).
Complete staged revascularization was associated with a lower rate of repeat revascularization (9% vs 36%, p=0.002) and need for re-hospitalization (13% reduction, p<0.002).
There were no significant difference in the mortality rate between the 2 groups.

Conclusions:
Staged complete multivessel PCI was safe and prevented recurrent hospitalization and unplanned repeat revascularization during 1 year follow-up in patients presenting with STEMI and MVD.









Powered by Eventact EMS